APN Resources (LON:APN – Get Free Report) issued its quarterly earnings results on Monday. The company reported GBX 12.20 EPS for the quarter, Digital Look Earnings reports. The business had revenue of £161.60 million during the quarter.
Here are the key takeaways from APN Resources’ conference call:
- FY 2026 delivered strong growth: Revenue rose 50.9% to £161.6 million and adjusted EBITDA increased 40.1% to £43.3 million, with revenue up in every region and 48 of the top 50 B2B customers growing.
- Management expects further growth in FY 2027, guiding for approximately £205 million in revenue and £49 million in adjusted EBITDA; it said strong momentum continued into the first quarter.
- Capacity and U.S. expansion are central to the growth plan: The U.K. production expansion is intended to raise annual capacity to £300 million, while the acquired U.S. facility has capacity of up to $300 million and is expected to become earnings-enhancing in FY 2027. Nutrablend is expected to contribute about $30 million of sales and single-digit EBITDA.
- Margins are expected to ease in FY 2027: Higher average whey protein costs and a greater contribution from the lower-margin U.S. business are expected to weigh on margins, although recent price increases should partly offset input costs.
- Cash generation may remain constrained near term: Working-capital needs rose as the company built inventory to meet demand and restarted the U.S. business; management does not expect a free-cash-flow rebound in the first half of FY 2027.
APN Resources Stock Up 0.2%
Shares of APN stock traded up GBX 0.50 during mid-day trading on Wednesday, reaching GBX 298. The stock had a trading volume of 780,950 shares, compared to its average volume of 1,812,572. The firm’s 50 day simple moving average is GBX 286.85 and its 200 day simple moving average is GBX 272.63. APN Resources has a one year low of GBX 162 and a one year high of GBX 356. The firm has a market cap of £745 million and a PE ratio of 26.85.
Insider Activity at APN Resources
Wall Street Analyst Weigh In
APN has been the subject of a number of research analyst reports. Canaccord Genuity Group reiterated a “buy” rating and set a GBX 365 price target on shares of APN Resources in a report on Monday. Deutsche Bank raised their price objective on shares of APN Resources from GBX 335 to GBX 350 and gave the stock a “buy” rating in a research note on Wednesday, August 26th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 370 target price on shares of APN Resources in a research report on Monday. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 323.75.
Check Out Our Latest Analysis on APN Resources
About APN Resources
Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world’s most trusted and innovative brand in the market. Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand – Applied Nutrition, ABE, BodyFuel, and Endurance.
Featured Stories
- Five stocks we like better than APN Resources
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
Receive News & Ratings for APN Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for APN Resources and related companies with MarketBeat.com's FREE daily email newsletter.
